The National Centre for Neuroimmunology and Emerging Diseases (NCNED) at Griffith University has made significant progress in understanding long COVID and Myalgic Encephalomyelitis, also known as Chronic Fatigue Syndrome (ME/CFS).
Researchers at NCNED conducted a study comparing brain neurochemical levels in patients with long COVID and ME/CFS to healthy controls using MRI. The study found that both conditions had elevated neurochemical levels, which may contribute to symptoms such as cognitive impairment, unrefreshing sleep, pain, and physical limitation.
These findings suggest a significant link between long COVID and ME/CFS. The director of NCNED, Professor Sonya Marshall-Gradisnik, stated that these findings build upon previous research and provide greater insight into the development and progression of these conditions.
The NCNED has a team of talented researchers and clinicians dedicated to studying these patients and has access to state-of-the-art technologies for scientific discoveries. The study, titled “Imbalanced Brain Neurochemicals in long COVID and ME/CFS: A Preliminary Study using MRI,” has been published in the American Journal of Medicine.
